Classes
Publications
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Alirocumab, Praluent(R) in the light of studies2016 | First Faculty of Medicine
- Prevention of atherosclerosis2012 | First Faculty of Medicine
- Treatment of HLP and DLP in diabetes2010 | First Faculty of Medicine
- Hyperlipoproteinaemia and dyslipoproteinaemia 1. Classification, diagnostics, cardiovascular, cardiometabolic, residual risk2010 | First Faculty of Medicine
- The effect of rosiglitazone on the expression of thrombogenic markers on leukocytes in type 2 diabetes mellitus2009 | First Faculty of Medicine, Faculty of Science
- Cardiabetes. Cardiovascular diseases and diabetes mellitus2009 | First Faculty of Medicine
- Lipid-lowering treatment in metabolic syndrome2009 | First Faculty of Medicine
- Rosuvastatine2009 | First Faculty of Medicine
- Clinical studies, evidence based medicina expectations and reality2009 | First Faculty of Medicine
Loading network view...